Texas House Bill HB3672

Texas 2021 - 87th Regular

Caption

Relating to the eligibility for Medicaid of persons diagnosed with sickle cell disease.

Impact

The introduction of HB 3672 is expected to significantly impact state laws surrounding Medicaid eligibility. By adding sickle cell disease to the criteria for medical assistance under Chapter 32 of the Human Resources Code, the bill highlights the state's commitment to addressing chronic health conditions that might otherwise be underserved in the current Medicaid framework. This legislative change may lead to improved health outcomes for affected individuals by providing consistent healthcare access and support.

Summary

House Bill 3672 aims to expand eligibility for Medicaid services to individuals diagnosed with sickle cell disease in Texas. The bill mandates the state to provide medical assistance to all persons who fall within this category, ensuring that they receive healthcare support as long as federal matching funds are available. This legislative effort recognizes the specific health needs of those living with sickle cell disease and aligns state Medicaide eligibility with present federal guidelines.

Contention

Notable points of contention that may arise include concerns regarding the fiscal implications of expanding Medicaid eligibility under the bill. Opponents could argue about the sustainability of the funding model, particularly if there is a considerable increase in the number of individuals applying for Medicaid due to this expansion. Additionally, the operational burden on state agencies to implement and effectively manage this new eligibility criterion may also be debated.